↓ Skip to main content

The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature

Overview of attention for article published in BMC Cancer, April 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
25 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature
Published in
BMC Cancer, April 2022
DOI 10.1186/s12885-022-09464-w
Pubmed ID
Authors

Anna Hagström, Ruba Kal Omar, Pete A. Williams, Gustav Stålhammar

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 2 8%
Researcher 1 4%
Student > Master 1 4%
Unknown 21 84%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Computer Science 1 4%
Medicine and Dentistry 1 4%
Materials Science 1 4%
Engineering 1 4%
Other 0 0%
Unknown 20 80%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 April 2022.
All research outputs
#8,176,951
of 25,390,692 outputs
Outputs from BMC Cancer
#2,218
of 8,962 outputs
Outputs of similar age
#154,461
of 437,923 outputs
Outputs of similar age from BMC Cancer
#47
of 284 outputs
Altmetric has tracked 25,390,692 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 8,962 research outputs from this source. They receive a mean Attention Score of 4.8. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 437,923 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 284 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.